Venus Medtech Hangzhou Inc

Venus Medtech (Hangzhou) Inc., together with its subsidiaries, researches, develops, manufactures, and sells bioprosthetic heart valves in Mainland China and internationally. Its products include transcatheter aortic heart valve replacement devices such as VenusA-Valve, VenusA-Plus, VenusA-Pro, and VenusA-Deluxe, as well as VenusP-Valve, a transcatheter pulmonary valve system for patients with moderate to severe pulmonary regurgitation, with or without right ventricular outflow tract stenosis. The company also develops Venus-Vitae, a balloon-expandable dry-tissue product; Venus-PowerX, a self-expanding dry-tissue product; Cardiovalve, a transcatheter valve replacement system for mitral regurgitation and in pivotal clinical trials for tricuspid regurgitation; and a renal artery denervation ablation system for hypertension. In addition, it offers procedural accessories including catheter sheath products and balloon catheters. Incorporated in 2009, the company is headquartered in Hangzhou, the People's Republic of China.